{"filings":[{"id":1473597,"accession_number":"0000950103-26-010269","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2026-07-06T21:00:42+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Clarivate sells Life Sciences & Healthcare business to Altaris for $600M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $600M: $500M cash at close, $25M deferred, $75M senior note.","Transaction expected to close by end of 2026; no shareholder vote required.","Buyer's termination fee of $33M guaranteed by Altaris funds.","Henry Levy, President of the business, gets retention agreement: RSU vesting, PSU cancellation, severance if terminated without cause within 6 months post-close."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1452958,"accession_number":"0001764046-26-000085","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2026-07-06T10:01:11+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate sells Life Sciences & Healthcare segment to Altaris for $600M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Deal value $600M: $500M cash at close, $25M deferred cash, $75M seller note.","Proceeds to reduce debt; transaction expected to close by end of 2026.","Reaffirms FY2026 outlook; LS&H to be classified as discontinued ops from Q3.","Expects non-cash goodwill impairment of $225-250M on LS&H segment.","Company sharpens focus on Academia & Government and Intellectual Property segments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":920437,"accession_number":"0001764046-26-000075","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2026-06-08T21:07:53+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Clarivate appoints Simon Webster as President of IP segment; Maroun Mourad departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Maroun Mourad, President IP, will depart June 9, 2026, and remain in advisory role through Sept 30, 2026.","Simon Webster appointed President IP effective June 10, 2026; former CEO of CPA Global.","Mourad receives $450,000 pro-rated 2026 bonus plus COBRA reimbursement under separation agreement.","CEO Matti Shem Tov highlights Webster's operating discipline and deep IP market expertise.","Company reaffirms full-year 2026 outlook previously provided on April 29, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":501678,"accession_number":"0001764046-26-000073","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2026-05-18T21:22:40+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Clarivate shareholders elect directors, approve compensation, ratify auditors at 2026 AGM","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 10 director nominees elected; votes in favor ranged from 92.0% to 99.9% of votes cast.","Advisory vote on executive compensation approved with 93.1% of votes cast in favor.","PricewaterhouseCoopers LLP ratified as independent auditors for fiscal year 2026 with 99.7% approval.","2027 Annual General Meeting scheduled for May 6, 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95277,"accession_number":"0001764046-26-000057","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate reports Q1 2026 earnings: organic revenue up 0.6%, reaffirms full-year outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues $585.5M, down 1.4% from prior year; organic revenue up 0.6%.","Subscription revenues grew 1.7% organically to $397.5M, driving recurring revenue growth.","Adjusted EBITDA improved to $241.2M from $233.2M; adjusted EPS $0.18 vs $0.14.","Generated $78.9M free cash flow; retired $143M in debt, including $100M accelerated repayment.","Net loss narrowed to $40.2M from $103.9M; company reaffirms 2026 financial outlook."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":585500000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108218,"accession_number":"0001764046-26-000043","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2026-03-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Clarivate amends executive severance plan; CEO now eligible, good reason triggers added","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO added as eligible ESP participant under amended severance plan.","Good reason resignation in connection with change in control qualifies for severance.","RSU vesting upon non-CIC termination: pre-2027 grants accelerated over 18 months; post-2027 grants prorated.","Upon CIC termination: all RSUs and PSUs vest in full; PSUs at HRCC-determined performance level.","Severance multiples: 18 months base + bonus (non-CIC); 24 months (CIC); COBRA lump sum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108217,"accession_number":"0001764046-26-000018","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q4 revenue $617M, down 7%; pursues LS&H sale; FY26 FCF ~$400M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $3.1M vs loss $191.8M; adjusted EPS $0.20 vs $0.21. Full-year adjusted EBITDA $1,001.8M.","Organic ACV grew 1.8% in FY2025; recurring revenue mix improved to 88% of total revenue.","Pursuing sale of Life Sciences & Healthcare; retained Morgan Stanley; proceeds to reduce leverage.","FY2026 outlook: Adj. EBITDA growth with ~200 bps margin expansion; FCF ~$400M at midpoint.","Returned $225M to shareholders via share repurchases in 2025 (56M shares)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":2455200000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108216,"accession_number":"0001764046-26-000005","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2026-02-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate posts AI-themed webinar; no financial updates or material news","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Feb 3, 2026: Posted 'Intelligence Amplified in the Age of AI' webinar to ir.clarivate.com.","Presentation covers AI trends; no earnings, guidance, or operational data disclosed.","Routine investor relations activity; no new financial or strategic information."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108215,"accession_number":"0001764046-26-000003","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["1.02","8.01","9.01"],"status":"ready","headline":"Clarivate redeems remaining $100M 2026 notes; buys back $225M shares in FY2025","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Redeemed remaining $100M principal of 4.50% senior secured notes due 2026 on Jan 30, 2026, using cash on hand.","Full redemption of 2026 Notes; Indenture satisfied and discharged effective January 30, 2026.","Repurchased ~21M ordinary shares for $75M in Q4 2025.","Full-year 2025 share repurchases totaled ~56M shares for $225M.","CFO Jonathan Collins stated the actions reflect disciplined capital allocation and balance sheet strengthening."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124653,"accession_number":"0001764046-25-000115","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q3 revenue flat at $623.1M, net loss narrows; raises 2025 revenue outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Organic ACV grew 1.6% YoY; recurring revenue mix improved to 88% of total revenue (up 800 bps).","Adjusted EBITDA $252.4M (down 4.5% YoY); adjusted EPS $0.18 vs $0.19.","Repurchased 11.7M shares in Q3; repaid $100M of debt, total debt $4.47B.","Organic subscription revenue +1.2% but total organic revenue -0.1% due to transactional decline.","Raises 2025 revenue outlook; full-year guidance numbers not yet disclosed in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":1838200000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141344,"accession_number":"0000950103-25-009919","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Clarivate increases revolving credit facility by $75M to $775M total","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 8 raised revolver commitments from $700M to $775M.","HSBC Bank USA ($50M) and Capital One ($25M) provided the $75M increase.","Increased commitments have same terms as existing facility, including interest rate and maturity.","No event of default exists as of the effective date; all conditions satisfied."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141343,"accession_number":"0001764046-25-000095","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q2 revenue $621.4M (-4.4% YoY); organic growth 0.5%; reaffirms 2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $621.4M, down 4.4% YoY due to divestitures; organic revenue +0.5%.","Net loss narrowed to $72.0M ($0.11 diluted EPS) from $304.3M ($0.46) in Q2 2024.","Adjusted EBITDA $261.6M vs $274.4M; adjusted diluted EPS $0.18 vs $0.20.","Recurring revenue mix improved to 88% of total in H1 2025 (from 80% in FY2024).","Repurchased 11.5M shares in Q2; H1 free cash flow $160.6M; 2025 guidance reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":1215100000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141342,"accession_number":"0001104659-25-071924","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Clarivate appoints Maroun S. Mourad as President, IP; Gordon Samson to retire by year-end","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gordon Samson to depart President, IP role on Sept 7, 2025; will remain non-executive until Dec 31, 2025.","Compromise agreement provides lump-sum cash of £1,458,552 and RSU acceleration for unvested RSUs vesting within 18 months.","Maroun S. Mourad (former Verisk Claims Solutions President) appointed President, IP effective Sept 8, 2025.","Board member Valeria Alberola resigns effective Dec 31, 2025 due to primary employment change; no disagreement cited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141341,"accession_number":"0001104659-25-069641","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Clarivate elects Kenneth Cornick to board; board expands to 11 members","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Effective July 22, 2025, Kenneth Cornick elected to Clarivate board, increasing director count from 10 to 11.","Cornick will serve on the Audit Committee; compensation as non-employee director per 2025 proxy statement.","Co-founded Clear Secure (CLEAR) in 2010, served as President and CFO until March 2025.","No arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159148,"accession_number":"0001104659-25-055262","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Clarivate closes $500M incremental term loan, redeems $500M of 2026 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $500M incremental term B loans added under credit agreement, maturing 2031, interest rate of Term SOFR + 3.25%.","Proceeds used to redeem $500M of 4.50% senior secured notes due 2026; $200M of notes remain outstanding.","New term loans not subject to amortization; CFO cites improved credit market conditions for the refinancing.","Refinancing extends majority of near-term debt maturity, reducing 2026 refinancing risk."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159147,"accession_number":"0001104659-25-050488","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Clarivate subsidiary announces conditional partial redemption of $500M of 4.50% Senior Secured Notes due 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Camelot Finance S.A., a Clarivate subsidiary, gives notice to redeem $500M of its 4.50% Senior Secured Notes due 2026.","Redemption is conditional upon completion of debt financings to fund the price; expected redemption date is May 30, 2025.","After the redemption, $200M of the 2026 Notes will remain outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159146,"accession_number":"0001104659-25-047349","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Clarivate shareholders approve all 2025 AGM proposals, including share repurchase authorization","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All five director nominees elected; e.g., Andrew Snyder received 609M votes for and 19M against.","Advisory vote on executive compensation passed: 619M for, 9M against.","PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2025.","Amended and Restated 2019 Incentive Award Plan approved (558M for, 70M against).","Authority granted for open-market share repurchases; 2026 AGM set for May 14, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159145,"accession_number":"0001764046-25-000061","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q1 rev $593.7M (-4.4% YoY); organic +0.3%; net loss widens; outlook reaffirmed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $593.7M (-4.4% YoY); organic revenue up 0.3%, recurring organic +0.6%.","Net loss $103.9M ($0.15 diluted) vs loss $75.0M ($0.14); adjusted EPS flat at $0.14.","Adjusted EBITDA $233.2M vs $236.3M; free cash flow $110.3M.","Repurchased $50M of ordinary shares in Q1; 2025 outlook reaffirmed.","Subscription revenue down 3.6% to $388.6M; organic transactional revs down 2.3%."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":593700000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177611,"accession_number":"0001104659-25-019215","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Michael J. Angelakis to retire from Clarivate board, effective May 7, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael J. Angelakis notified his retirement from the Board, effective upon re-election at 2025 Annual Meeting on May 7, 2025.","He withdrew from consideration for re-election as a Board member.","Angelakis confirmed his decision is not due to any disagreement with the Company, management, or Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177610,"accession_number":"0001764046-25-000010","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2025-02-19T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q4 revenue $663M (-3% YoY), adj. EPS $0.21; initiates strategic alternatives review","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year 2024 revenue $2.56B (-2.7% YoY); net loss -$636.7M improved from -$911.2M.","Adjusted EBITDA full year $1.06B vs $1.12B prior; free cash flow $357.5M, down 28.7%.","Repurchased $200M shares and pre-paid $198M debt in 2024; new $500M buyback authorization for 2025-26.","Initiated review of strategic alternatives including potential divestitures; Morgan Stanley and Moelis advising.","Provides 2025 outlook with focus on subscription and re-occurring revenue growth."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":2556700000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194312,"accession_number":"0001104659-24-128963","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-12-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate authorizes $500M share repurchase program for 2025-2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized $500M share repurchase via open-market buys from Jan 1, 2025 to Dec 31, 2026.","New program replaces existing one expiring Dec 31, 2024; $300M repurchased under prior, $200M in H2 2024.","Prepaid $75M term-loan debt in Q4 2024, bringing total 2024 debt prepayments to $133M.","CEO Matti Shem Tov cites strong confidence in driving growth and balanced capital allocation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194310,"accession_number":"0001104659-24-128494","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K/A","filed_at":"2024-12-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Clarivate amends Richard Roedel board retirement effective date to Jan 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director Richard Roedel retirement originally set for Dec 31, 2024; now effective Jan 1, 2025.","No other changes from the July 23, 2024 original 8-K filing.","Roedel notified board of retirement on July 23, 2024; date amended on Dec 10, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194311,"accession_number":"0001764046-24-000139","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q3 revenue down 3.9%, posts net loss; withdraws 2024 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $622.2M (-3.9% YoY); organic revenue -2.6% with transactional sales down 13.6%.","Net loss $65.6M vs. profit $12.3M a year ago; diluted EPS -$0.09.","Adjusted diluted EPS $0.19 (-9.5%); Adjusted EBITDA $264.4M (-6.0%), margin 42.5%.","CEO Matti Shem Tov called results unsatisfactory; Company removed 2024 outlook citing CEO transition and Value Creation Plan.","Free cash flow $126.3M in Q3 (+24.2% YoY), but YTD FCF fell 20.4% to $298.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":1893700000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210652,"accession_number":"0001764046-24-000098","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q2 2024 revenue down 2.8%, adjusted EPS $0.20, reaffirms FY outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenues $650.3M, down 2.8% YoY; organic revenue declined 0.6% with subscription growth offset by transactional/other.","Net loss $304.3M vs $123.1M loss a year ago; adjusted diluted EPS $0.20, down 4.8% or $0.01.","Adjusted EBITDA $274.4M (42.2% margin), down 3.7%; free cash flow $60.3M, down 42.5%.","Reaffirmed FY2024 outlook: revenue $620-640M, adjusted EBITDA $72-76M, free cash flow $45-55M.","Total debt decreased $53.1M to $4,717.2M since Dec 31, 2023, driven by accelerated repayment."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":1271500000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210651,"accession_number":"0001104659-24-086317","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Clarivate appoints Matti Shem Tov as CEO effective Aug 9; Jonathan Gear steps down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gear receives $4.375M lump sum, pro-rated bonus, accelerated RSUs, and 18 months COBRA reimbursement.","Shem Tov gets $900k base salary, 100% target bonus, $3.5M initial equity grant, and $500k sign-on RSU.","Retention awards: Jonathan Collins $2M RSU; Bar Veinstein, Henry Levy, Gordon Samson each $1M RSU, cliff-vest one year.","Gear remains non-executive employee through Nov 1, 2024; departure not due to disagreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210650,"accession_number":"0001104659-24-082366","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-07-24T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Richard Roedel to retire; Valeria Alberola to succeed as Audit Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Richard Roedel will retire from Clarivate Board for health reasons, effective Dec 31, 2024.","Valeria Alberola, Board member since May 2021, expected to succeed Roedel as Audit Committee Chair.","Roedel confirmed his retirement is not due to any disagreement with the company or its management."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229013,"accession_number":"0001104659-24-059939","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-05-10T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Clarivate shareholders elect 12 directors, approve say-on-pay and auditor at 2024 AGM","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 12 director nominees elected with majority support; notable against votes for Wendell Pritchett (45M), Richard Roedel (41M).","Advisory say-on-pay passed with 582.5M votes for, 4.8M against, 0.3M abstain.","Ratification of PwC as independent auditor for FY2024 approved with 603.8M for, 2.1M against.","Next Annual General Meeting scheduled for May 7, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229012,"accession_number":"0001764046-24-000062","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q1 net loss $93.8M; revenue down 1.3%; adjusted EPS -22%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss per diluted share $0.14 vs income $0.04 YoY; adjusted diluted EPS $0.14, down 22.2%.","Revenue $621.2M (-1.3% YoY); organic revenue -1.7% as subscription +2.4% offset by transactional -11.4%.","Adjusted EBITDA $236.3M (-6.5%); margin 38.0% (-220 bps). Free cash flow $111.8M (-33.5%).","Debt reduced $47.7M to $4.72B; cash $361.8M. Reaffirmed FY2024 outlook."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":621200000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247624,"accession_number":"0001104659-24-030268","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-03-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Clarivate enters investment pact with Exor; Exor to nominate director, subject to standstill","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exor, holding 10.1% of Clarivate shares, will nominate its COO Suzanne Heywood for board election at 2024 annual meeting.","Investor agreement includes standstill: Exor cannot acquire >17.5% of outstanding shares or make public offers.","Standstill expires if Exor ownership falls below 5%, nominee is not elected, or company initiates certain transactions.","Agreement dated March 4, 2024; full text filed as Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247623,"accession_number":"0001764046-24-000015","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q4 net loss $863M on $845M impairment; adj EPS $0.23 +4.5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenues $683.7M +1.2% YoY; organic revenue growth 0.1%.","Net loss attributable to ordinary shares $863M due to $844.7M non-cash goodwill impairment; diluted EPS loss $1.30.","Adjusted EBITDA $298.2M (43.6% margin), adj net income $163.4M, adj diluted EPS $0.23 +4.5%.","FY 2023 free cash flow $501.7M +63.7%; total debt reduced $301M to $4,770.3M.","CEO launches multi-year transformation plan to accelerate organic growth; plans to divest non-core assets."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":2628800000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247622,"accession_number":"0001104659-24-009119","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-02-01T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Clarivate refinances $2.15B term loan, lowers margin and extends revolver to 2029","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $2.150 billion term loan tranche matures in 2031 at SOFR + 275 bps, down from prior margin.","Revolving credit facility replaced with $700 million facility maturing 2029 (was 2027).","Term loans amortize at 1.00% per annum quarterly; proceeds used to refinance existing term loans.","CFO cites “oversubscribed interest” and lower annual cash interest costs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247621,"accession_number":"0001104659-24-005379","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2024-01-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Clarivate launches $2.2B term loan refinancing; expects $800M-$900M goodwill impairment in Q4 2023","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Refinancing of 2026 Term Loan B with new $2.2B, 7-year facility maturing in 2031, subject to market conditions.","Expects non-cash goodwill impairment charge of $800M-$900M in Q4 2023 for IP and Life Sciences & Healthcare segments.","Impairment lowers GAAP net loss forecast but no impact on 2023 revenue, Adjusted EBITDA, or other non-GAAP guidance.","CFO states refinancing proactively extends debt maturities and improves financial flexibility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265084,"accession_number":"0001764046-23-000110","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q3 revenues $647M, up 1.8%; adj. EPS $0.21, up 5%; reaffirms FY23 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $647.2M, up 1.8% vs Q3 2022; organic revenue growth 1.7%.","Adjusted net income $152.6M, up 6.2%; adjusted diluted EPS $0.21, up 5.0%.","Academia & Government and LS&H segments each delivered highest quarterly revenue growth in past year.","Free cash flow $101.7M, down from $140.4M due to timing of working capital.","Company reaffirms full-year 2023 financial outlook."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":1945100000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282287,"accession_number":"0001104659-23-101386","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-09-18T23:59:59+00:00","items":["3.03","8.01","9.01"],"status":"ready","headline":"Clarivate terminates Tax Benefits Preservation Plan effective Oct 1, 2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board unanimously approved termination; plan expires at end of day October 1, 2023.","Plan originally adopted Dec 2022 to protect U.S. NOLs; limited 5% holders from acquiring >4.9% of shares.","Original expiration was Oct 31, 2023; termination accelerates the date by 30 days.","Press release issued Sept 18, 2023; plan no longer needed or board determined to end early."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282286,"accession_number":"0001764046-23-000086","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-08-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q2 net loss $141.7M; revenue down 2.6%; lowers 2023 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $668.8M (-2.6% YoY); organic revenue -0.4%. Net loss $141.7M vs. income $43.7M prior year.","Adjusted EBITDA $284.9M (+3.8%), margin 42.6% (+270bps); adjusted diluted EPS $0.21 (-4.5%).","Free cash flow $104.8M (+111.6%); total debt reduced $150.5M to $4.92B.","FY2023 revenue guidance lowered to $2.685-2.745B from $2.75-2.84B; adjusted EPS to $0.83-0.86 from $0.98-1.03.","Academia & Government improved; IP and Life Sciences & Healthcare fell short of expectations."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":1297900000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282285,"accession_number":"0001104659-23-086395","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-08-01T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Shareholders authorize open-market share repurchases at Clarivate","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved share repurchase authorization at July 27, 2023 meeting.","Votes: 601,593,444 in favor, 1,587,194 against, 518,321 abstained.","Approval required two-thirds of votes cast; authorization for open-market purchases.","Buyback applies to ordinary shares; no specific amount or timeline disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.15,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301435,"accession_number":"0001764046-23-000073","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-06-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate presents at conferences; no material financial details in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["CEO Jonathan Gear presenting at William Blair Growth Stock Conference on June 6, 2023.","Also presenting at Stifel 2023 Cross Sector Insight Conference on June 7, 2023.","Presentation includes business overview and financial performance, but no specific guidance or new data disclosed.","Exhibit 99.1 is a furnished presentation; no forward-looking statements or updated metrics provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301434,"accession_number":"0001104659-23-063855","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-05-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate extends share buyback authorization to Dec 2024, reduces to $500M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board reduced authorization from $1B to $500M and extended through Dec 31, 2024.","Resumption of repurchases follows progress toward target leverage ratio under 4x net debt/EBITDA by end of 2023.","Company will seek shareholder approval to buy up to 100M shares at $1-$35 per share in open market.","CEO cites confidence in strategy and commitment to balanced capital allocation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301433,"accession_number":"0001104659-23-058473","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-05-10T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Clarivate 2023 AGM: all director nominees elected, say-on-pay and auditor ratified","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders elected all 11 director nominees; each received >94% of votes cast excluding broker non-votes.","Advisory say-on-pay proposal passed with 522.2M for (95.5%) vs 24.6M against.","Ratification of PwC as independent auditor for 2023 approved with 560.4M for (99.99% of votes cast).","Next Annual General Meeting set for May 7, 2024; details to follow in proxy statement.","Approximately 83% of outstanding shares were represented at the meeting (560.5M of 675.5M)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":301432,"accession_number":"0001764046-23-000069","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q1 revenue $629M (-5% YoY); adj. EPS $0.18; CRO departs; reaffirms FY outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $629.1M (-5% YoY; -3.1% constant currency); organic revenue -0.2% due to MarkMonitor divestiture and FX.","Net income attributable to ordinary shares $24.7M ($0.04 diluted EPS); adjusted net income $130.9M ($0.18 adjusted diluted EPS).","Cash flow strong: net operating cash $227.5M, free cash flow $168.2M; debt repayment accelerated by $125M.","Reaffirmed full-year 2023 outlook; Web of Science subscription growth inflection noted.","Chief Revenue Officer Steen Lomholt-Thomsen to depart July 1, 2023; will stay as advisor through Dec 31, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":629100000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321252,"accession_number":"0001764046-23-000030","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-03-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate reiterates 2023 outlook at Investor Day; revenue $2.63B-$2.73B, Adj. EBITDA $1.10B-$1.16B","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirmed 2023 guidance: revenue $2.63B-$2.73B, organic growth 2.75%-3.75%.","Adjusted EBITDA expected $1.10B-$1.16B; margin 42.0%-42.5%.","Adjusted diluted EPS guidance $0.75-$0.85; free cash flow $450M-$550M.","Management presented business update at Investor Day on March 9, 2023; replay available.","Guidance based on ~740M fully diluted shares; no further acquisitions assumed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":321251,"accession_number":"0001764046-23-000011","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2023-03-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q4 rev $675.3M (+20.4%); adj EPS $0.22 (-4.3%); organic rev +0.5%; FY net loss $4.04B on impairment","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 revenue $675.3M (+20.4% YoY); organic revenue +0.5%; subscription +2.5% organic.","Q4 adj. net income $164.0M (+0.5%); adj. diluted EPS $0.22 (-4.3%).","Full-year net loss $4,035.6M due to $4,449.1M non-cash goodwill impairment.","Full-year adj. EBITDA $1,112.7M (+39.0%); adj. free cash flow $521.8M (+13.6%).","2023 outlook provided but specific guidance numbers not in filing text; Investor Day March 9."],"consensus_eps_estimate":null,"consensus_eps_actual":-6.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":2659800000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339363,"accession_number":"0001104659-22-129321","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2022-12-22T23:59:59+00:00","items":["1.01","3.03","5.03","8.01","9.01"],"status":"ready","headline":"Clarivate adopts tax benefits preservation plan to protect over $1.0B in NOLs","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board declared dividend of one preferred share purchase right per ordinary share payable Jan 1, 2023.","Plan triggers at 4.9% ownership; existing 4.9%+ shareholders grandfathered but cannot acquire more.","Rights become exercisable at $42 per share, entitling holder to purchase shares/units worth twice that.","Plan expires Oct 31, 2023, unless earlier terminated or redeemed at $0.001 per right.","As of Sep 30, 2022, Clarivate estimated U.S. federal NOL and interest carryforwards exceed $1.0 billion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339362,"accession_number":"0000950103-22-021239","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2022-12-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate CEO outlines three-segment structure, 2023 Investor Day, and strategic priorities after 100 days","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Jonathan Gear passed 100-day mark; letter details key objectives for next year.","Company reorganized into three segments: Academia & Government, Life Sciences & Healthcare, Intellectual Property; search for respective Presidents underway.","Focus on five priority pillars: go-to-market, new solutions, insights & analytics, workflow, value-added services.","Investor Day scheduled for March 9, 2023 in New York to share details on growth roadmap.","Management cites 80% recurring revenue, 45,000 customers, ~$25B addressable market opportunity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339361,"accession_number":"0001104659-22-128438","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2022-12-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Clarivate board reduced from 14 to 11; three directors resign voluntarily","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Directors Balakrishnan Iyer, Kosty Gilis, Roxane White resigned effective Dec 19, 2022.","Board size cut from 14 to 11; 10 of 11 directors are now independent.","45% of board members are female or racially diverse post-reduction.","Continuing directors include Chair Andrew Snyder, CEO Jonathan Gear, and eight others."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339360,"accession_number":"0001764046-22-000171","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2022-12-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Clarivate furnishes 2021 financial data; no narrative summary extractable from raw XBRL","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filing is an 8.01 furnishing of financial statements (Exhibit 99) for fiscal year 2021.","XBRL-encoded data includes balance sheet, income statement, cash flows, segment info, and note references.","References to ProQuest acquisition and debt refinancing are present but no new quantitative results summarized.","No press release text or key metrics (EPS, revenue, guidance) are directly readable in provided text.","Given the raw data format, no material change from previously reported information can be identified."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339359,"accession_number":"0001104659-22-118941","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2022-11-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate presents at RBC conference with business overview and financial outlook","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company management presented at RBC Capital Markets TMT conference on November 15, 2022.","Presentation includes overview of Clarivate's business and financial outlook.","No specific financial figures or updated guidance were disclosed in the filed exhibit text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339358,"accession_number":"0001764046-22-000166","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2022-11-08T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Clarivate Q3 revenue $635.7M (+43.8% YoY), net loss $4.4B on goodwill impairment; lowers 2022 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $635.7M (+43.8% YoY); organic revenue +1.2%; subscription organic +4.3%.","Net loss $4,434.4M due to $4,448.6M non-cash goodwill impairment; adjusted net income $143.7M (+26.5%).","Adjusted EBITDA $271.6M (+42.9%); margin 42.7%; adjusted diluted EPS $0.20 (+25%).","FY2022 guidance cut: revenue $2,645-2,695M (prev $2,700-2,780M), adjusted EPS $0.86-0.91 (prev $0.90-1.00).","Transactional revenues organic -9.4%; LS&H segment underperformed on delayed deal closings."],"consensus_eps_estimate":null,"consensus_eps_actual":-6.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":1984500000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":339357,"accession_number":"0001104659-22-113181","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2022-11-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate completes divestiture of MarkMonitor to Newfold Digital for $302.5M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale price $302.5M; $10.6M expected from deferred closings in foreign jurisdictions.","Net proceeds to be used to reduce outstanding debt.","Divestiture allows Clarivate to focus on core intellectual property portfolio (IP lifecycle management and IP intelligence).","Previously announced on September 12, 2022; Evercore and Blank Rome advised Clarivate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":356731,"accession_number":"0001104659-22-099074","cik":1764046,"company_name":"CLARIVATE PLC","ticker":"CLVT","form_type":"8-K","filed_at":"2022-09-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Clarivate presents at two investor conferences; financial outlook included in presentation materials","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company presented at Barclays Global Financial Services Conference on Sep 12, 2022 and will present at Goldman Sachs Communacopia + Technology Conference on Sep 15, 2022.","Exhibit 99.1 contains an overview of the business and financial outlook, but specific guidance numbers are not disclosed in the provided exhibit text.","Presentation materials include forward-looking statements and non-GAAP financial measures, with reconciliations in the appendix.","No material quantitative updates on revenue, earnings, or guidance were extractable from the furnished documents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1671551070.7664094,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-09-12T23:59:59+00:00|356731"}